Takeda Pharmaceutical Total Long Term Liabilities 2010-2024 | TAK

Takeda Pharmaceutical total long term liabilities for the quarter ending September 30, 2024 were $38.165B, a 2.63% decline year-over-year.

  • Takeda Pharmaceutical total long term liabilities for 2024 were $38.1B, a 0.54% increase from 2023.
  • Takeda Pharmaceutical total long term liabilities for 2023 were $37.896B, a 20.39% decline from 2022.
  • Takeda Pharmaceutical total long term liabilities for 2022 were $47.604B, a 15.06% decline from 2021.

Takeda Pharmaceutical Total Long Term Liabilities 2010-2024 | TAK

  • Takeda Pharmaceutical total long term liabilities for 2024 were $38.1B, a 0.54% increase from 2023.
  • Takeda Pharmaceutical total long term liabilities for 2023 were $37.896B, a 20.39% decline from 2022.
  • Takeda Pharmaceutical total long term liabilities for 2022 were $47.604B, a 15.06% decline from 2021.